Cargando…
Dengvaxia controversy: impact on vaccine hesitancy
Autores principales: | Fatima, Khunsha, Syed, Najah Irfan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Edinburgh University Global Health Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214489/ https://www.ncbi.nlm.nih.gov/pubmed/30410732 http://dx.doi.org/10.7189/jogh.08-020312 |
Ejemplares similares
-
Dengvaxia: the world’s first vaccine for prevention of secondary dengue
por: Tully, Danielle, et al.
Publicado: (2021) -
The Nikki Minaj Effect: The impact of social media disinformation on vaccine hesitancy in the Caribbean
por: Maharaj, Sandeep B, et al.
Publicado: (2021) -
A review of Dengvaxia®: development to deployment
por: Thomas, Stephen J., et al.
Publicado: (2019) -
SARS-CoV-2 Vaccination in India: Considerations of Hesitancy and Bioethics in Global Health
por: Sarkar, Mohammad Abdullah, et al.
Publicado: (2021) -
PrEP: controversy, agency and ownership
por: Cairns, Gus P, et al.
Publicado: (2016)